Read + Share
Kegasawa T, Sakamori R, Maesaka K, Yamada R, et al. Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib
on Hepatocellular Carcinoma. Dig Dis Sci 2020 Jun 17. pii: 10.1007/s10620-020-06380.
PMID: 32556820
|
 |
|
Kegasawa T, Sakamori R, Maesaka K, Yamada R, et al. Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib
on Hepatocellular Carcinoma. Dig Dis Sci 2020 Jun 17. pii: 10.1007/s10620-020-06380.
PMID: 32556820
|
|
|
|